{"id":379457,"date":"2020-11-12T07:33:31","date_gmt":"2020-11-12T12:33:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=379457"},"modified":"2020-11-12T07:33:31","modified_gmt":"2020-11-12T12:33:31","slug":"strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/","title":{"rendered":"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">DUBLIN, Ireland\u00a0and\u00a0TREVOSE, Pa., Nov.  12, 2020  (GLOBE NEWSWIRE) &#8212; Strongbridge Biopharma plc\u00a0(Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will participate in fireside chats at the Stifel and Jefferies 2020 Virtual Healthcare Conferences.<\/p>\n<p>Details for the presentations are as follows:<\/p>\n<ul type=\"disc\">\n<li>The Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020, from 10:40 \u2013 11:10 a.m. ET. Following is a link to access the webcast: <a href=\"https:\/\/urldefense.com\/v3\/__https:\/wsw-dot-yamm-track.appspot.com\/Redirect?ukey=1HjlbbjREvyecIVPiPOrnqWnlTC92j96eAVIytZ0pm9A-214729144&amp;key=YAMMID-29068129&amp;link=https*3A*2F*2Fwsw.com*2Fwebcast*2Fstifel27*2Fsbbp*2F2079792__;JSUlJSUlJQ!!L4T48vo5TZ1tBsrb8gVPOA!Ggb0Jg-ouV2u29HnSY-yjCt7HLjFnBWLUzY3l5zIb17PBpxAVsduMCagSpkA47uAjKU$\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>https:\/\/wsw.com\/webcast\/stifel27\/sbbp\/2079792<\/u><\/a>\u00a0\u00a0\n<\/li>\n<li>The Jefferies Virtual Healthcare Conference on Thursday, November 19, 2020, from 7:55 \u2013 8:25 p.m. GMT. Following is a link to access the webcast: <a href=\"https:\/\/urldefense.com\/v3\/__https:\/wsw.com\/webcast\/jeff141\/sbbp\/1833975__;!!L4T48vo5TZ1tBsrb8gVPOA!GWOIp_Ib4_0ZN4uOg8GDaVSSewFTq70-jAgF9k6OZKRlh96rNNoVgW_Ip6xL3VcatiE$\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>https:\/\/wsw.com\/webcast\/jeff141\/sbbp\/1833975<\/u><\/a><\/li>\n<\/ul>\n<p>The Company\u2019s presentations will be webcast live and archived on the \u201cEvents &amp; Presentations\u201d page in the Investor section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JdfeBOhNqKknzCgXw8Yuy9QzQJW9Z6jRTa91i0tLbi5WpEHDrCt79-tXOuKq5yeVI5bs55DLfAaM6JgONJKzVAX4FJVQ8a7c0gv3L6oyQS8lwNFv0Co8iTvvAYAl5eIqpGYubNE0z26zk5cC88q9TRJUbJKYoxoglREpuJScbtOa3rN3JegF6hi881m1PJ85KHK1P5wzDEn6qKt9DI2WRxrN64IJScSr3ScdlKM0iR4AOcKMuhvWOwk5W8-RZbArgF1FqDRSY3n8v4RSuv1pTywW0qf1fMdhlMoxahW1Lv0JKXN7xqCuljawNNhLN4wPBf9LDrhfStQ08dBglwe7pYE8HzP60eFHvk2p9TFyjuPrSaL8OgFKvnARmX-7CKZRfTSOp3j4nQ3-WLJyMFNhpBdNH9LWmwyfJPUIW426sADfLRDD5g9IKjeyNa-4iPBhtL4_AIysHq_TsVwarE1kTCr6MIHuItRDscShCk_Bj0C6J4-winam3YAmY4fxU3qM05K4Y7eeqZ8q2PsVZr4w5z-PpJ3GJRCRW8TVS6JmuV85ipQ5fLtA1avZVtbmIIpXECdBmtBa740gRtgUzmNLs-AcO09r3krJqjuJxBeMLCmSxjWIfHb94crMt8vHEzIuWlZ2Z93B206lV5abalrvlt0OrmN-w82qRRI-TdLVG1osJbXN8BHoh-NMV3-yJOv18LZkH_y2OWHIdIXfNP256VpT58UrApaqvLNey7t_YYe04SpVwTisWd2KIRiRAwhJ4FRO453_wRqrJJGvUSCe3A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.strongbridgebio.com<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About Strongbridge Biopharma<\/strong><br \/>\n        <br \/>Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Strongbridge\u2019s rare endocrine franchise includes RECORLEV\u00ae (levoketoconazole), a cortisol synthesis inhibitor currently being studied in Phase 3 clinical studies for the treatment of endogenous Cushing\u2019s syndrome, and veldoreotide extended release, a pre-clinical next-generation somatostatin analog being investigated for the treatment of acromegaly and potential additional applications in other conditions amenable to somatostatin receptor activation. Both RECORLEV and veldoreotide have received orphan drug designation from the FDA and the European Medicines Agency. The Company\u2019s rare neuromuscular franchise includes KEVEYIS\u00ae (dichlorphenamide), the first and only FDA-approved treatment for hyperkalemic, hypokalemic, and related variants of primary periodic paralysis. KEVEYIS has orphan drug exclusivity in the United States.<\/p>\n<p>\n        <strong>Contacts<\/strong>:<\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>Solebury Trout<br \/>Mike Biega<br \/>+1 617-221-9660<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YyvKbQQqpKamIjV-ACZSLvvo2AtoZXoEMaAe8e0m78Rd92yl_0hLO134u5HX3JtG79CF07_2dbXz5OpGu4gxo19Od0aYR2G2LjOQxVnPVxtdzFKP6ekH4GStFMbKTJcPthjJYuhLi7Ed9DRvkYN_75CFutqzUzjSFWPhxI4Oyk4o4Rmpp5ZTUuMIepWwGprQYQLBc6uPWZn7K5OEWOV4ZOIkIdmmooCknaCK6E_VPk6gByUrE93rt-fpZoOipIRYm5dA76JZXNYi7BIvQeJO1g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>mbiega@soleburytrout.com<\/u><\/a><\/p>\n<p>\n        <strong>Corporate <\/strong><br \/>\n        <strong>&amp; <\/strong><br \/>\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>Elixir Health Public Relations<br \/>Lindsay Rocco<br \/>+1 862-596-1304<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6B-Hnw0QIL8UdXlrCgksCBTlixTwhCqBYPQhyfelVMsxCroqS5kj-dhr_2P9hbGWlz1pY8Jod2xHr00S7gCEfKRCGtAJ5RZPU_dQryqg1uLF33wXSzgqKnrLwCZ6EZEQ-RluHkwuGLEfe17UlQevKHrDtuHi8l_MuGjk7CMfNCymR5DemVH1uE3Ib6uNjPlu2w_-ox--cvuMmNoVDhThOYj0fFo6hHGuOKxIp0Xn2QIo3rf-mEnYrjvogs-RBFyYhJrDbfCy4Cno_ekR_uLq0A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>lrocco@elixirhealthpr.com<\/u><\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN, Ireland\u00a0and\u00a0TREVOSE, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Strongbridge Biopharma plc\u00a0(Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will participate in fireside chats at the Stifel and Jefferies 2020 Virtual Healthcare Conferences. Details for the presentations are as follows: The Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020, from 10:40 \u2013 11:10 a.m. ET. Following is a link to access the webcast: https:\/\/wsw.com\/webcast\/stifel27\/sbbp\/2079792\u00a0\u00a0 The Jefferies Virtual Healthcare Conference on Thursday, November 19, 2020, from 7:55 \u2013 8:25 p.m. GMT. Following is a link to access the webcast: https:\/\/wsw.com\/webcast\/jeff141\/sbbp\/1833975 The Company\u2019s presentations will be webcast live and archived on the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-379457","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DUBLIN, Ireland\u00a0and\u00a0TREVOSE, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Strongbridge Biopharma plc\u00a0(Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will participate in fireside chats at the Stifel and Jefferies 2020 Virtual Healthcare Conferences. Details for the presentations are as follows: The Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020, from 10:40 \u2013 11:10 a.m. ET. Following is a link to access the webcast: https:\/\/wsw.com\/webcast\/stifel27\/sbbp\/2079792\u00a0\u00a0 The Jefferies Virtual Healthcare Conference on Thursday, November 19, 2020, from 7:55 \u2013 8:25 p.m. GMT. Following is a link to access the webcast: https:\/\/wsw.com\/webcast\/jeff141\/sbbp\/1833975 The Company\u2019s presentations will be webcast live and archived on the &hellip; Continue reading &quot;Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T12:33:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences\",\"datePublished\":\"2020-11-12T12:33:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/\"},\"wordCount\":306,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/\",\"name\":\"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=\",\"datePublished\":\"2020-11-12T12:33:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk","og_description":"DUBLIN, Ireland\u00a0and\u00a0TREVOSE, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) &#8212; Strongbridge Biopharma plc\u00a0(Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that management will participate in fireside chats at the Stifel and Jefferies 2020 Virtual Healthcare Conferences. Details for the presentations are as follows: The Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020, from 10:40 \u2013 11:10 a.m. ET. Following is a link to access the webcast: https:\/\/wsw.com\/webcast\/stifel27\/sbbp\/2079792\u00a0\u00a0 The Jefferies Virtual Healthcare Conference on Thursday, November 19, 2020, from 7:55 \u2013 8:25 p.m. GMT. Following is a link to access the webcast: https:\/\/wsw.com\/webcast\/jeff141\/sbbp\/1833975 The Company\u2019s presentations will be webcast live and archived on the &hellip; Continue reading \"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-12T12:33:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences","datePublished":"2020-11-12T12:33:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/"},"wordCount":306,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/","name":"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=","datePublished":"2020-11-12T12:33:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4MjM3MiMzODE3MTU0IzIwMjAwMjU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/strongbridge-biopharma-plc-announces-participation-in-two-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Strongbridge Biopharma plc Announces Participation in Two Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=379457"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/379457\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=379457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=379457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=379457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}